The Atomic Spectroscopy Group at the National Institute of Standards and Technology, which provides definitive measurements integral to developing biomedical instrumentation that helps diagnose health ...
The new Propelus Prototype Centers in Oregon and Minnesota will help customers accelerate the pace of life-saving innovation.
Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released separate draft guidance on the use of the technology in the development of ...
On average, around 4,500 drugs and medical devices are pulled from shelves across the United States each year. 1 This alarming statistic underscores the importance of controlling and mitigating risk ...
TOLEDO, Ohio--(BUSINESS WIRE)--NAMSA®, the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and ...
If you’re a medical device inventor, developer, or start-up with an innovative medical device idea, choosing the perfect medical device contract manufacturer is essential to the success of your ...
This certificate program is designed to prepare biomedical engineers to understand the environment into which their innovations will be placed and the users who will interact with them. Professionals ...
Some medical technologies are just plain cool. But tech that’s only cool is never enough. It must solve specific health problems, improve each patient’s quality of care, and be easy to use. To create ...
TOKYO & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SanBio Company Limited (hereafter, “the Company”) hereby announces that it entered into a business partnership agreement with D&P Bioinnovations, Inc.
Saideep Nakka is a principal systems engineer specializing in medical device innovation, with over 9 years of industry ...
Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B ...